We previously constructed and prepared truncated tLAP, and confirmed that tLAP inhibits liver fibrosis by affecting TGF-β1 activation (Song et al. 2022; Qiu et al. 2023). The gene discussed is SSR2; the disease is Hepatic fibrosis.